CVS Health Corporation CVS
89.13
4.08
4.80%
as of 25 Sep
- Market cap
- $108.5B
- P/E
- 23.3×
Follow CVS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
CVS Health Corporation (CVS) Net income
CVS Health Corporation's net income for fiscal 2025 was $1.7B, down 62.3% from $4.6B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.9B. Over the past ten years it has ranged from −$596.0M (fiscal 2018) to $8.4B (fiscal 2023); the current reading is higher than 18% of that period. CVS Health Corporation ranks 4th of 12 Healthcare Plans companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.7B | (62.32%) |
| FY2024 | $4.6B | (45.20%) |
| FY2023 | $8.4B | 93.39% |
| FY2022 | $4.3B | (45.84%) |
| FY2021 | $8.0B | 11.08% |
| FY2020 | $7.2B | 8.46% |
| FY2019 | $6.6B | — |
| FY2018 | −$596.0M | — |
| FY2017 | $6.6B | 24.52% |
| FY2016 | $5.3B | 1.53% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $3.0B | 1.29% |
| Mar 2026 | $3.0B | 1.16% |
| Dec 2025 | $2.9B | — |
| Sep 2025 | −$4.0B | — |
| 42 more quarters | Free account |
Against its own ten years
Low −$596.0M
High $8.4B
Ten-year median
$5.3B
Current reading's percentile
18
Net income against peers
| Company | Net income |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $14.9B |
| CI Cigna Group compare | $7.0B |
| ELV Elevance Health, Inc. compare | $4.9B |
| CVS CVS Health Corporation | $4.9B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. compare | $550.9M |
| MOH Molina Healthcare, Inc compare | −$7.0M |
| CLOV Clover Health Investments, Corp. compare | −$18.4M |
| CNC Centene Corporation compare | −$5.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CVS
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement